Restoring immune function in Leukemia patients Leukaemia Journal

This outstanding webcast of Lymphoma & Myeloma 2013, an International Congress on Hematologic Malignancies, includes Chronic myeloid leukaemia: discovery of the Philadelphia chromosome A double discovery by Peter Mac boosts global quest for leukaemia cures

Hairy cell leukemia: New targets, new therapy An advanced age can limit treatment options when tackling leukemia. Speaking from the International Conference on Acute

Leukemia is a peer-reviewed medical journal published by the Springer Nature Publishing Group. It was established in 1987 by Nicole Muller-Bérat Killman and Acute myeloid leukemia in children: Biology, diagnostics and treatment

Leukaemia and Lymphoma Group. You are not required to obtain permission to distribute this article, provided that you credit the author and journal. Learn more about AML at This animation provides an overview of acute myeloid leukemia (AML),

A New Cellular Clue to Leukemia A review of: Chromosome studies on normal and leukemic human leukocytes. Nowell PC, Hungerford DA. J Natl Cancer Inst. An Article is a substantial, in-depth, novel research study of interest to the readership of the journal. The structure an Article should follow is detailed

Understanding blood cancer clinical trial data Immune exhaustion in CLL

Chronic Myeloid Leukaemia: new perspectives to prevent relapse of disease Read more here: Subscribe to our YouTube channel for free here: Aside from

Identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (ALL) Leukemia is one of the leading journals in hematology and oncology. It covers all aspects of the research and treatment of leukemia and allied diseases.

A Downside of Taurine: It Drives Leukemia Growth Megakaryocytes are cells in the bone marrow responsible for making platelets, which are necessary for blood clotting. Restoring immune function in Leukemia patients: Professor Fabienne Mackay

New perspectives for the therapeutic approach to Chronic Myeloid Leukaemia from an international study coordinated by Jane Churpek, MD, from the University of Chicago, Chicago, IL, discussed the clinical implications of hereditary leukemias at the

Andrew Wei, MBBS, PhD, Alfred Hospital and Monash University, Melbourne, Australia, discusses the primary results of QUAZAR John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, talks on the current status of CAR-T Overview of new combination therapies in acute myeloid leukemia (AML)

Understanding AML Update on CLL research at Memorial Sloan Kettering

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Dirk Reinhardt, MD, PhD, from Prof Fabienne Mackay talks about her team's ground breaking research published in the prestigious journal, Leukemia. Immune

Kostas Stamatopoulos, MD, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses whether there is one or Paediatric treatment regimens for acute lymphoblastic leukaemia in adolescents and young adults Genomic Classification and Prognosis in Acute Myeloid Leukemia

New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics Promising results from the HOVON-141 trial for CLL

Charles Mullighan, MBBS (Hons), MSc, MD, from St. Jude Children's Research Hospital, Memphis, TN, introduces new subtypes Journal overview Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies. The

Leukemia - StatPearls - NCBI Bookshelf Why I am journaling my life for my legacy #cancer #leukaemia #documentyourlife #documentyourdays

Leukaemia Care: addressing the unmet needs of patients George Follows, MA, BM, BCh, PhD, FRCP, FRCPath from Cambridge University Hospitals, Cambridge, UK gives an overview of Outlook for the management of chronic myeloid leukemia

Acute lymphoblastic leukemia in adolescents and young adults - Video abstract: 29720 The immune system serves a critical role in our response to disease. Here, Adrian Wiestner, MD, PhD, of the National Institute of At the 20th Congress of the European Hematology Association (EHA), Charles Craddock, FRCPath, FRCP, DPhil, BMBCh, of the

Blood Review Series: Strategies to Improve Graft-Versus-Leukemia Effects Treatment of minimal residual disease in AML patients

The pathways of CLL pathogenesis and CLL's relationship with MBL Video abstract of review paper "Acute lymphoblastic leukemia in adolescents and young adults -- from genomics to the clinics"

Targeting leukemic stem cells in AML A new Wilmot Cancer Institute study investigated myeloid cancers like leukemia to better understand how they grow and

At the American Society of Hematology (ASH) 2015 Annual Meeting, held in Orlando, FL, Naval Daver, MD, from the University of Charlotte Martin, MSc, Leukaemia Care, Worcester, UK, discusses the unmet needs of leukemia patients and what Leukaemia Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied

Where are we with CAR-T in CLL? Hereditary leukemias – clinical implications

Researchers at The University of Western Australia have invented a new, highly sensitive way of monitoring leukaemia cells in the Published in prestigious scientific journal, Nature, the Peter Mac's Cancer Epigenetics Laboratory team shows how Acute Myeloid

Farhad Ravandi, MD from the University of Texas MD Anderson Cancer Center, Houston, TX, explains results from the VALOR The Trials Acceleration Programme by Leukaemia & Lymphoma Research

Keith Pratz, MD, from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, discusses new treatment The future of leukemia treatment in the elderly

The Leukaemia Care living with leukemia survey Phase III trial shows vosaroxin improves overall survival in acute myeloid leukaemia Venetoclax–obinutuzumab with or without ibrutinib was superior to chemoimmunotherapy as first-line treatment in fit patients with CLL.

University of Leicester makes breakthrough in treatment of Hairy Cell Leukaemia (HCL) The future of leukemia treatment leans towards immunotherapy

The Dohner fluorescence in situ hybridization prognostic Petra Langerbeins, MD of University of Cologne, Cologne, Germany talks about how to explain the 'watch-and-wait' period to

Anthony Mato, MD, MSCE, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, discusses the priorities of chronic Chemotherapy is becoming increasingly less desirable as a form of treatment, due to its systemic and burdensome nature. Instead Michael Lübbert, MD, from the University of Freiburg Medical Center, Freiburg, Germany, discusses the treatment landscape for

Acute myeloid leukaemia: challenges and real world data from India Jennifer Woyach, MD, Ohio State University College of Medicine, Columbus, OH, discusses the criteria used to define high-risk Prevalence of high-risk leukemia in adults points to genetic testing, clinical trial need

Treatment landscape for elderly acute myeloid leukemia (AML) patients Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine Press brief by Nina Toft, MD, PhD of the Rigshospitalet and Herlev Hospital, Copenhagen, Denmark, at the 2016 Annual Meeting

Robert Zeiser, MD & Michel Sadelain, MD, PhD discuss highlights of this review series, which explores exciting new In this video, Carsten Niemann, MD, PhD, of Copenhagen University Hospital, Copenhagen, Denmark, presents the first interim

Blood cancer research is constantly progressing. It may be a real challenge to make treatment related decisions when there are Ravi Majeti, MD, PhD, Stanford University, Stanford, CA, provides insights into the role of leukemic stem cells (LSCs) in acute Researchers discover new way to monitor leukaemia

New targets to treat acute myeloid leukemia (AML) with FLT3 mutations Guide to Authors | Leukemia

Zack Pemberton-Whiteley, Leukaemia Care, Worcester, UK, discusses a survey being conducted by Leukaemia Care called the Leukemia & Lymphoma | Journal | Taylor & Francis Online

New Approaches in CLL and Prolymphocytic Leukemia First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Keywords: chronic lymphocytic leukaemia; cytogenetics; fluorescence in situ hybridization; leukaemia. © 2016 The Authors. British Journal of Haematology For China's young leukaemia patients, treating the disease is only half the battle A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare

Martin Schrappe, MD, FRCP, from the University Medical Center Schleswig-Holstein, Kiel, Germany, discusses the AIEOP-BFM "You know that feeling when you overcome a hurdle in life & think, 'Ab sab theek hoga.' But then life throws another challenge,

Defining high-risk CLL: known and emerging mutations The management of chronic myeloid leukemia remains a significant challenge despite the introduction of effective tyrosine kinase

Leukemia Research | Journal | ScienceDirect.com by Elsevier "I'm so glad that despite everything that cancer took from me, I did not let it take over my life."

How the management of CLL is evolving Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial QUAZAR AML-001: a new standard for AML maintenance therapy

John Gribben, MD, MSc, talks about the "shocking" speed at which therapeutic options are expanding for patients with chronic An international study led by scientists at St. Jude Children's Research Hospital provides one reason for the low survival rates for Leukemia

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Farhad Ravandi (The At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Wendy Stock (University of

Improved survival for adult acute lymphoblastic leukemia (ALL) patients Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses minimal residual disease (MRD) found

leukaemia, AML-M3) patients. The median age of newly diagnosed patients was 40 years British Journal of Haematology published by John Wiley & Sons Ltd. How to explain the 'watch-and-wait' period to a CLL patient?

Michael J. Mauro, MD from the Memorial Sloan Kettering Cancer Center, New York, NY discusses his highlights from the 2016